---
figid: PMC6637205__41419_2019_1782_Fig4_HTML
figtitle: 'Multiple signaling pathways in Sertoli cells: recent findings in spermatogenesis'
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Sus scrofa
- Cricetus cricetus
- Phodopus sungorus
- Vicugna pacos
- Bison bonasus
- Gallus gallus
- Sparus aurata
- Homo sapiens
- Zika virus
organisms_ner:
- Vicugna pacos
- Mus musculus
- Sus scrofa
- Sparus aurata
- Bos taurus
- Rattus norvegicus
- Gallus gallus
- Homo sapiens
- Danio rerio
pmcid: PMC6637205
filename: 41419_2019_1782_Fig4_HTML.jpg
figlink: /pmc/articles/PMC6637205/figure/Fig4/
number: F4
caption: MAPKs consist of JNKs, ERKs, and p38 MAPKs. After MAPKKK is activated by
  the signal, MAPKK and then MAPK are activated via phosphorylation. The activated
  MAPK will then phosphorylate its substrates. IL-1α activates via the p38 MAPK pathway,
  then the phosphorylated p38 MAPK phosphorylates Elk-1 and allows Elk-1 to bind onto
  TGIF and pSp1 + E2F motifs, which thus stimulates JAM-B transcription (red). Activation
  of the ERK and JNK pathways induced by TGF-β3 will promote JAM-B mRNA destabilization
  (orange). When TAB1 and CD2AP both interact with TGF-β3-TGFβRI, the activated p38
  MAPK and ERK pathways will downregulate expression of occludin, ZO-1 and cadherin,
  and disturb SCs-GCs AJs and BTB (blue) . TNF-α administration will decrease occludin
  and ZO-1 via the p38 MAPK pathway but also increase ICAM-1 via the JNK pathway,
  thus regulating the AJ and TJ dynamics (purple). FGF-2 activates the ERK pathway
  to stimulate GDNF expression, thus enhancing SSCs self-renewal (green)
papertitle: 'Multiple signaling pathways in Sertoli cells: recent findings in spermatogenesis.'
reftext: Fei-Da Ni, et al. Cell Death Dis. 2019 Aug;10(8):541.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.945974
figid_alias: PMC6637205__F4
figtype: Figure
redirect_from: /figures/PMC6637205__F4
ndex: d5105919-defa-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6637205__41419_2019_1782_Fig4_HTML.html
  '@type': Dataset
  description: MAPKs consist of JNKs, ERKs, and p38 MAPKs. After MAPKKK is activated
    by the signal, MAPKK and then MAPK are activated via phosphorylation. The activated
    MAPK will then phosphorylate its substrates. IL-1α activates via the p38 MAPK
    pathway, then the phosphorylated p38 MAPK phosphorylates Elk-1 and allows Elk-1
    to bind onto TGIF and pSp1 + E2F motifs, which thus stimulates JAM-B transcription
    (red). Activation of the ERK and JNK pathways induced by TGF-β3 will promote JAM-B
    mRNA destabilization (orange). When TAB1 and CD2AP both interact with TGF-β3-TGFβRI,
    the activated p38 MAPK and ERK pathways will downregulate expression of occludin,
    ZO-1 and cadherin, and disturb SCs-GCs AJs and BTB (blue) . TNF-α administration
    will decrease occludin and ZO-1 via the p38 MAPK pathway but also increase ICAM-1
    via the JNK pathway, thus regulating the AJ and TJ dynamics (purple). FGF-2 activates
    the ERK pathway to stimulate GDNF expression, thus enhancing SSCs self-renewal
    (green)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB3
  - TGFBR1
  - FGF2
  - TGFBR2
  - TAB1
  - CD2AP
  - RHO
  - CDC42
  - TNF
  - Tgfb3
  - Tgfbr1
  - Fgf2
  - Tgfbr2
  - Tab1
  - Cd2ap
  - Akt1
  - Rho
  - Rhod
  - Ea2
  - Mdk
  - Cdc42
  - ras
  - Hras
  - Kras
  - Rem1
  - Tjp1
  - Map2k3
  - Zhx2
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Map2k1
  - Mapk3
  - Mapk8
  - Jam2
  - Tgif1
  - Calm1
  - Tnfrsf1a
  - Tnfrsf1b
  - Tnf
  - Map3k1
  - FGFR2
  - LOC396567
  - TJP1
  - MAP2K3
  - MAPK3
  - MAPK8
  - TNFRSF1B
  - CYP11A1
  - tgfb3
  - fgf2
  - tgfbr2
  - tab1
  - cd2ap
  - rho
  - cdc42
  - tnfb
  - tnfa
  - MAPK14
  - Map2k7
  - Pck1
  - OPN1MSW
  - CRK
  - TGIF1
  - LITAF
  - PCDH11X
  - FGFR1
  - FGFR3
  - FGFR4
  - FGFRL1
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAP2K4
  - MAPK9
  - MAPK10
  - JAM2
  - IL10
  - CALM2
  - CALM3
  - TNFRSF1A
  - MTG1
  - AMACR
  - MAP3K1
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - tgfbr1a
  - tgfbr2b
  - rnd2
  - cdc42l
  - rab1ab
  - map2k6
  - mapk14a
  - map2k1
  - mapk3
  - mapk8b
  - jam2a
  - tgif1
  - tnfrsf1b
  - hoxa5a
  - tnfrsfa
  - GTP
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
